ACORDA THERAPEUTICS INC Insider Trading for December 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACORDA THERAPEUTICS INC for December 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 28 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 14.66 | 50,000 | 732,760 | 5,543,926 | 5.6 M to 5.5 M (-0.89 %) |
Dec 28 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 14.66 | 50,000 | 732,820 | 5,593,926 | 5.6 M to 5.6 M (-0.89 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 2,500 | 0 | 107,787 | 105.3 K to 107.8 K (+2.37 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Grant | A | 0.00 | 2,200 | 0 | 5,853 | 3.7 K to 5.9 K (+60.22 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Grant | A | 0.00 | 2,200 | 0 | 5,853 | 3.7 K to 5.9 K (+60.22 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Grant | A | 0.00 | 2,300 | 0 | 7,471 | 5.2 K to 7.5 K (+44.48 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 5,980 | 0 | 493,534 | 487.6 K to 493.5 K (+1.23 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Grant | A | 0.00 | 2,100 | 0 | 32,350 | 30.3 K to 32.4 K (+6.94 %) |
Dec 26 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 13.24 | 40,506 | 536,097 | 5,643,926 | 5.7 M to 5.6 M (-0.71 %) |
Dec 21 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 14.03 | 40,000 | 561,368 | 5,684,432 | 5.7 M to 5.7 M (-0.70 %) |
Dec 21 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.03 | 1,900 | 30,461 | 5,724,432 | 5.7 M to 5.7 M (-0.03 %) |
Dec 21 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 15.87 | 3,100 | 49,203 | 5,726,332 | 5.7 M to 5.7 M (-0.05 %) |
Dec 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.88 | 30,000 | 506,496 | 5,729,432 | 5.8 M to 5.7 M (-0.52 %) |
Dec 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.97 | 50,000 | 848,445 | 5,759,432 | 5.8 M to 5.8 M (-0.86 %) |
Dec 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.49 | 41,853 | 690,102 | 5,809,432 | 5.9 M to 5.8 M (-0.72 %) |
Dec 17 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.15 | 28,796 | 464,978 | 5,851,285 | 5.9 M to 5.9 M (-0.49 %) |
Dec 17 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.27 | 33,061 | 537,760 | 5,880,081 | 5.9 M to 5.9 M (-0.56 %) |
Dec 13 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.30 | 100,000 | 1,629,790 | 5,913,142 | 6 M to 5.9 M (-1.66 %) |
Dec 13 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.30 | 200,000 | 3,259,500 | 6,013,142 | 6.2 M to 6 M (-3.22 %) |
Dec 11 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 19.07 | 35,000 | 667,531 | 6,213,142 | 6.2 M to 6.2 M (-0.56 %) |
Dec 11 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 18.77 | 25,210 | 473,071 | 6,248,142 | 6.3 M to 6.2 M (-0.40 %) |
Dec 07 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 18.43 | 40,711 | 750,340 | 6,273,352 | 6.3 M to 6.3 M (-0.64 %) |
Dec 07 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 20.60 | 3,090 | 63,659 | 6,314,063 | 6.3 M to 6.3 M (-0.05 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 20.52 | 3,067 | 62,947 | 105,287 | 108.4 K to 105.3 K (-2.83 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 20.66 | 4,119 | 85,081 | 1,568 | 5.7 K to 1.6 K (-72.43 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 20.20 | 1,072 | 21,656 | 5,687 | 6.8 K to 5.7 K (-15.86 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 20.55 | 2,493 | 51,232 | 3,653 | 6.1 K to 3.7 K (-40.56 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Sell | S | 20.56 | 753 | 15,478 | 5,171 | 5.9 K to 5.2 K (-12.71 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.60 | 3,620 | 74,554 | 487,554 | 491.2 K to 487.6 K (-0.74 %) |
Dec 03 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 20.70 | 100,000 | 2,069,500 | 6,317,153 | 6.4 M to 6.3 M (-1.56 %) |
Dec 03 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 20.48 | 75,000 | 1,536,015 | 6,417,153 | 6.5 M to 6.4 M (-1.16 %) |
Dec 03 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 20.20 | 50,000 | 1,009,860 | 6,492,153 | 6.5 M to 6.5 M (-0.76 %) |